Loading...
Elevance Health Inc.
ELV•NYSE
Healthcare
Medical - Healthcare Plans
$280.43
$-16.17(-5.45%)
Elevance Health Inc. (ELV) Financial Performance & Statements
Review Elevance Health Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.19%
↑ 3.19%
Operating Income Growth
-9.62%
↓ 9.62%
Net Income Growth
-0.12%
↓ 0.12%
Operating Cash Flow Growth
-27.95%
↓ 27.95%
Operating Margin
22.84%
↑ 22.84%
Gross Margin
60.40%
↑ 60.40%
Net Profit Margin
2.83%
↑ 2.83%
ROE
12.51%
↑ 12.51%
ROIC
55.33%
↑ 55.33%
Elevance Health Inc. (ELV) Financial Statements
Explore quarterly and annual reports for Elevance Health Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $48.89B | $45.44B | $45.15B | $43.65B |
| Cost of Revenue | $4.98B | $0.00 | $32.95B | $30.57B |
| Gross Profit | $43.91B | $45.44B | $12.20B | $13.07B |
| Gross Profit Ratio | $0.90 | $1.00 | $0.27 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$40.79B | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $5.30B | $44.84B | $10.48B | $10.05B |
| Total Costs & Expenses | $10.28B | $44.84B | $43.43B | $40.62B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $344.00M | $340.00M | $300.00M | $280.00M |
| Depreciation & Amortization | $0.00 | $398.00M | $329.00M | $335.00M |
| EBITDA | $3.14B | $1.34B | $2.002B | $3.60B |
| EBITDA Ratio | $0.06 | $0.03 | $0.04 | $0.08 |
| Operating Income | $3.14B | $0.00 | $1.71B | $3.03B |
| Operating Income Ratio | $0.06 | $0.00 | $0.04 | $0.07 |
| Other Income/Expenses (Net) | -$344.00M | -$541.00M | -$339.00M | -$40.00M |
| Income Before Tax | $2.80B | $606.00M | $1.37B | $2.99B |
| Income Before Tax Ratio | $0.06 | $0.01 | $0.03 | $0.07 |
| Income Tax Expense | $613.00M | $193.00M | $365.00M | $685.00M |
| Net Income | $2.18B | $418.00M | $1.02B | $2.30B |
| Net Income Ratio | $0.04 | $0.009 | $0.02 | $0.05 |
| EPS | $9.64 | $1.84 | $4.36 | $9.91 |
| Diluted EPS | $9.61 | $1.81 | $4.36 | $9.85 |
| Weighted Avg Shares Outstanding | $226.40M | $227.48M | $233.03M | $232.20M |
| Weighted Avg Shares Outstanding (Diluted) | $227.20M | $231.10M | $233.10M | $233.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan